$SYF

SYF Maintained by TD Cowen -- Price Target Lowered to $86.00

TD Cowen maintained a 'Buy' rating for Synchrony Financial (SYF) but lowered its price target to $86.00 from $90.00. The stock is currently trading at $72.27, which is 8.6% above its GF Value™ of $66.56. Synchrony Financial has a GF Score™ of 88/100, indicating strong performance, but insider activity shows significant selling.

Original reporting
Published Oct 6, 2026, 3:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 7:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$SYF
Bearish
high confidence
Mentioned
$SYF
Relevance
6/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$SYFBearishLow
01

Why it matters

Analyst price‑target reduction may influence short‑term price action and sentiment.

02

Market read

The downgrade in price target could affect SYF and comparable credit‑services stocks.

03

What to watch

Insider selling of $847k could indicate internal concerns not reflected in the rating.

Relevance 6/10Novelty 5/10Timing: post-market today

Background

Synchrony Financial is a major private‑label credit‑card provider with a market cap of ~$23.5B.

Company-level read

Ticker impact

$SYFBearishHigh confidence
Context

TD Cowen lowered SYF price target to $86 from $90, maintaining a Buy rating.

Expected impact

likely pressure as the market prices in the lower target

Evidence & confidence

The price target cut signals a more cautious outlook, which may prompt short-term selling.

Market effects

May prompt re‑evaluation of other credit‑card issuers in the financial services sector.

Limited to U.S. financial services equities.

Minimal global impact.

Counterpoint

Some investors may view the lower target as a buying opportunity given the still‑positive rating.

Key entities

  • TD Cowen

    Provided the rating update and new price target.

  • Synchrony Financial

    Subject of the rating update.

Related articles

$WEAVMed

Weave integrates CareCredit financing into platform

Weave (WEAV) integrated CareCredit financing from Synchrony (SYF) into its platform, allowing healthcare practices to view patient credit status and initiate payments. A survey found 43% of Weave customers would use the service exclusively. The feature aims to streamline payment discussions and processes.

$GNRCMed

GNRC, LEU, AXP, SYF, COF Trending With Analysts

Analysts upgraded Generac (GNRC) to Buy with targets of $280 (KeyBanc) and $303 (Piper Sandler), citing Amazon's $8B deal and data-center growth. Centrus Energy (LEU) initiated at Buy with a $167 target by Guggenheim. American Express (AXP) initiated at Buy with a $380 target, highlighting its fee-based model. Synchrony (SYF) and Capital One (COF) initiated at Hold with $81 and $219 targets, respectively.

$SYFMed

SYF Maintained by UBS -- Price Target Lowered to $81.00

UBS maintained a Neutral rating on Synchrony Financial (SYF) but lowered its price target to $81.00 from $87.00. GuruFocus values SYF at $66.54, suggesting an 8.0% overvaluation. Insiders have sold $847,287 in shares over the past three months. SYF has a GF Score of 89/100, indicating strong performance but with some financial strength concerns.

$SYFMed

No Discount Survives an AI That Can’t See It

Synchrony partnered with OpenAI to integrate promotional financing into ChatGPT, aiming to make store-branded credit cards discoverable. Target already offers AI-driven shopping with loyalty benefits via Microsoft Copilot and ChatGPT, reporting strong digital traffic growth. Visa and Braze executives highlight the importance of AI-readable loyalty programs. Sephora also launched a ChatGPT app for rewards integration. Synchrony's move aims to keep up with AI-driven commerce trends.